SUMMARY
Small RhoGTPases direct cell shape changes and movements during tissue morphogenesis. Their activities are tightly regulated in space and time to specify the desired pattern of actomyosin contractility that supports tissue morphogenesis. This is expected to stem from polarized surface stimuli and from polarized signaling processing inside cells. We examined this general problem in the context of cell intercalation that drives extension of the Drosophila ectoderm. In the ectoderm, G protein-coupled receptors (GPCRs) and their downstream heterotrimeric G proteins (Ga and Gbg) activate Rho1 both medial-apically, where it exhibits pulsed dynamics, and at junctions, where its activity is planar polarized. However, the mechanisms responsible for polarizing Rho1 activity are unclear. We report that distinct guanine exchange factors (GEFs) activate Rho1 in these two cellular compartments. RhoGEF2 acts uniquely to activate medial-apical Rho1 but is recruited both medial-apically and at junctions by Ga 12/13 -GTP, also called Concertina (Cta) in Drosophila. On the other hand, Dp114RhoGEF (Dp114), a newly characterized RhoGEF, is required for cell intercalation in the extending ectoderm, where it activates Rho1 specifically at junctions. Its localization is restricted to adherens junctions and is under Gb13F/Gg1 control. Furthermore, Gb13F/Gg1 activates junctional Rho1 and exerts quantitative control over planar polarization of Rho1. Finally, we found that Dp114RhoGEF is absent in the mesoderm, arguing for a tissuespecific control over junctional Rho1 activity. These results clarify the mechanisms of polarization of Rho1 activity in different cellular compartments and reveal that distinct GEFs are sensitive tuning parameters of cell contractility in remodeling epithelia.
INTRODUCTION
Contractile actomyosin networks power cell shape changes during tissue morphogenesis [1] [2] [3] . By pulling on actin filaments anchored to E-cadherin complexes at adherens junctions, non-muscle myosin-II (Myo-II) motors generate tensile forces whose amplitude and orientation determine the nature of cell-and tissue level-deformation [4] [5] [6] [7] [8] . Consequently, specific cortical Myo-II patterns predict specific cell shape changes underlying tissue dynamics [9, 10] . During Drosophila embryogenesis, apical constriction of cells underlies mesoderm invagination [11, 12] . Apical constriction is driven by a strictly medial-apical pool of Myo-II [13] . In contrast, during elongation of the ventro-lateral ectoderm (also called germband extension), cells intercalate as a consequence of a polarized shrinkage of dorso-ventral interfaces or ''vertical junctions'' [14] [15] [16] . This process depends on both a medialapical pulsatile Myo-II pool and a planar-polarized junctional Myo-II pool to remodel cell interfaces during tissue extension [15] [16] [17] .
The small guanosine triphosphatase (GTPase) Rho1 is a chief regulator of actomyosin networks in these developmental contexts [18] [19] [20] , though Rac1 can also activate actin in epithelial cells [21] . Rho1 cycles between an inactive GDP-bound conformation and an active GTP-bound form. Rho1-GTP binds to and thereby activates the kinase Rok, which in turn phosphorylates non-muscle Myo-II regulatory light chain (MRLC; Sqh in Drosophila). This promotes assembly of Myo-II minifilaments on actin filaments and induces contractility of actomyosin networks. Two families of proteins regulate Rho cycling: Rho guanine nucleotide exchange factors (RhoGEFs), which promote the exchange of GDP to active GTP-bound form of Rho1 and Rho GTPase-activating proteins (RhoGAPs) that inactivate Rho1 by promoting GTP hydrolysis to GDP [22] . Recent work has explored the contribution of specific GEFs and GAPs during tissue invagination [23] [24] [25] . In the mesoderm, apically localized RhoGEF2, the Drosophila ortholog of the mammalian RH-RhoGEFs subfamily (p115RhoGEF/PDZRhoGEF/LARG) [26] [27] [28] , and the RhoGAP Cumberland tune and restrict Rho1 signaling to the apical cell cortex [24] . How Rho1 activity and therefore the Myo-II activity patterns are controlled during cell intercalation where Rho1 is active both medial-apically and at junctions remains unclear. The Rho1-Rok core pathway activates both medial-apical and junctional Myo-II in the ectoderm [18, 19] . Activation of Rho1 occurs via different molecular mechanisms in these distinct cellular compartments downstream of G protein-coupled receptors (GPCRs) and their associated heterotrimeric G proteins [29] . Fog, a GPCR ligand initially reported for its function during apical constriction in the mesoderm [30] [31] [32] , is also required for cell intercalation in the ectoderm [29] . It is thus a general regulator of medial-apical Rho1 activation in the embryo, mediated by Ga 12/13 /Cta and RhoGEF2. In the Drosophila embryo, the FogGa 12/13 /Cta-RhoGEF2 signaling module specifically controls medial-apical Rho1 activity. The secreted Fog ligand binds to GPCRs Smog and Mist, whose GEF activity catalyzes the dissociation of active Ga 12/13 /Cta-GTP from Gbg [29, 33] . Free Ga 12/13 / Cta-GTP then binds to RhoGEF2 (inferred from RhoGEF2 mammalian orthologs) [28] , which in turn activates Rho1, Rok, and Myo-II at the apical membrane. In the mesoderm, apical targeting of RhoGEF2 activity is driven by both active Ga 12/13 /Cta and enhanced by the mesoderm-specific apical transmembrane protein T48, which binds the PDZ domain of RhoGEF2 [34] . Whether Ga 12/13 /Cta is sufficient to localize RhoGEF2 activity medial-apically in the ectoderm, where T48 is not expressed, is unknown.
A separate biochemical module was hypothesized to control and polarize junctional Rho1 independently in the ectoderm, but the underlying molecular mechanisms remain unclear. The pair-rule genes even-skipped (eve) and runt were the first upstream regulators of planar polarized junctional Myo-II identified in the ectoderm [14, 35] . The Toll receptors (Toll2/6/8) are transmembrane proteins whose expression in stripes is regulated by Eve and Runt and who are essential for the polarization of Myo-II [36] . However, the molecular mechanisms linking Tolls to Rho1 activation remain uncharacterized. The GPCR Smog and the two heterotrimeric G protein subunits Gb13F/ Gg1 are involved in the tuning of Rho1 activity at ectodermal junctions [29] . However, in the absence of a direct junctional Rho1 activator, e.g., a specific RhoGEF, it is difficult to understand how these upstream regulators polarize the GTPase activity. In this study, we aim to dissect the spatial and temporal control of both medial-apical and junctional Rho1 activity in the ectoderm.
RESULTS

RhoGEF2 Controls Medial-Apical Rho1 Activity in the Ectoderm
We used a Rho1-GTP biosensor that consists of a fusion protein between mEGFP (A206K monomeric EGFP) and the Rhobinding domain (RBD) of anillin, which binds selectively to active Rho1-GTP (Ani-RBD::GFP) [19] in the ectoderm. Ani-RBD::GFP localization shows that active Rho1 is present both medial-apically ( Figure 1A , top panel right) and at adherens junctions ( Figure 1A , bottom panel right), where it is planar polarized (white arrowheads) as previously reported [19] . Importantly, the Rho1 activity pattern is not a consequence of a differential subcellular enrichment in Rho1 protein. Indeed, Rho1 is uniformly distributed along cell membrane in contrast to the planar polarized Rho1-GTP biosensor (Figures S1A-S1C). Hence, Rho1 regulators spatially control Rho1 activity in this tissue. RhoGEF2 is a major activator of the medial-apical Myo-II pool, but not the junctional pool in the ectoderm [29] . Therefore, we first asked whether medial-apical Rho1 activity is specifically decreased upon RhoGEF2 knockdown. The Rho1-GTP biosensor was analyzed in embryos expressing short hairpin RNA (shRNA) against RhoGEF2 driven by maternally supplied Gal4 (mata-Gal-VP16). We found that Rho1-GTP was indeed decreased apically but strikingly preserved at junctions (Figures 1B-1D ; Video S1), consistent with the specific regulation of medial-apical Myo-II by RhoGEF2 previously described [29] .
These shRNA studies could not rule out a residual RhoGEF2 population signaling at junctions. Therefore, we generated RhoGEF2 maternal and zygotic mutants with germline clones using a null allele for RhoGEF2, DRhoGEF2 l(2)04291 [37] , and observed a complete loss of medial-apical Myo-II together with an expanded cell surface area ( Figure 1E ). Interestingly, junctional Myo-II persisted in RhoGEF2 mutant embryos and its planar polarity was not affected ( Figures 1F and 1G ). Adherens junctions were also found deeper in the tissue relative to wild-type junctions, consistent with a role of apical contractility in the positioning of apical junctions [31, 38] . Thus, loss of RhoGEF2 affects medial-apical, but not junctional, Rho1 signaling. Overall, in the ectoderm, RhoGEF2 is specifically (C and D) Quantifications of mean medial-apical Rho1-GTP and mean junctional Rho1-GTP intensities in control and RhoGEF2 shRNA embryos. Medial Rho1-GTP is decreased in the RhoGEF2 knockdown condition while junctional Rho1-GTP intensity is unchanged compared to control. (E) Top panels: apical (0 mm), junctional (2 mm), and lateral (8 and 12 mm) confocal z sections of ectodermal cells in control and RhoGEF2 germline clone embryos expressing Myo-II::mCherry and a-catenin::YFP, a junctional marker. Medial-apical Myo-II is lost in mutant embryos, and Myo-II is still detected at junctions in this condition (white arrowheads). Although half of the RhoGEF2 germline clone embryos express RhoGEF2 zygotically, no rescue has been observed for Myo-II apical levels, suggesting that maternally loaded RhoGEF2 mainly controls the process in a wild-type embryo at this stage. required for Rho1 medial-apical activation, but not for junctional activation and planar polarization.
Regulation of RhoGEF2 Localization and Activity in the Ectoderm
The spatial distribution of Rho1 signaling could stem from specific control over the localization and/or activity of upstream Rho1 regulators [23, 24] . Therefore, we analyzed RhoGEF2 localization in the ectoderm by imaging embryos expressing RhoGEF2::GFP [24] , whose expression rescues early embryonic phenotypes in RhoGEF2 mutants, and Myo-II::mCherry. RhoGEF2 was enriched both apically and at cell junctions (Figure 2A ), in agreement with previous reports [24, 39] . Additionally, we detected a highly dynamic pool of RhoGEF2 « comets » in the cytoplasm (Figure 2A , middle right panel, yellow arrowheads), consistent with the observation that RhoGEF2 localizes at microtubule growing (plus) ends in S2 culture cells [40] . To test this further in vivo, we analyzed embryos co-expressing RhoGEF2::RFP and GFP-tagged EB1, a microtubule plus end tracking protein, and found that indeed RhoGEF2::RFP co-localizes with EB1::GFP comets ( Figure 2B ; Video S2). The much broader spatial distribution of RhoGEF2 with respect to where RhoGEF2 is specifically required for Rho1 activation led us to ask whether RhoGEF2 activity is spatially segregated in the ectoderm. Ga 12/13 /Cta and the membrane anchor T48 promote RhoGEF2 activation at the cell membrane in Drosophila upon GPCR activation [34, 40] . Both regulators cooperate to recruit RhoGEF2 to the apical membrane in the mesoderm, where it activates Rho1 signaling. T48 anchors RhoGEF2 via a direct PDZ domain interaction. By analogy to its mammalian homolog p115RhoGEF, RhoGEF2 is thought to bind to active Ga 12/13 /Cta via its N-terminal RH domain. A conformational change then dislodges the autoinhibitory N-terminal tail of the RhoGEF from its DH-PH domains, making them accessible for binding to Rho1 and membrane lipids [28] . Although this allosteric regulation by active Ga 12/13 /Cta is sufficient to increase p115RhoGEF binding to the membrane, it is not clear whether a full activation of the RhoGEF requires additional control. T48 is not expressed in the ectoderm [34] and therefore cannot account for RhoGEF2 activity at the apical membrane, though T48 overexpression in the ectoderm can increase apical Myo-II activation (data not shown) similar to RhoGEF2 overexpression [29] . We previously showed that the Ga 12/13 /Cta-dependent increase of medial-apical Myo-II is abolished upon RhoGEF2 knockdown in the lateral ectoderm, indicating that RhoGEF2 transduces the signal downstream of Ga 12/13 /Cta [29] . Therefore, Ga 12/13 /Cta is a strong candidate for controlling RhoGEF2 localization and activity in the ectoderm. We examined RhoGEF2 localization in Ga 12/13 / Cta-depleted embryos and in embryos expressing constitutively active Ga 12/13 /Cta, Ga 12/13 /Cta Q303L (a mutant that mimics the GTP-bound state). Apical and junctional RhoGEF2 levels in Ga 12/13 /Cta knockdown embryos ( Figure 2C ) significantly decreased ( Figures 2D and 2E ). This shows that Ga 12/13 /Cta contributes to localizing RhoGEF2 in both compartments. Strikingly, in Ga 12/13 / Cta Q303L embryos, RhoGEF2 was strongly enriched everywhere at the cell surface, namely the apical membrane, at junctions and along the lateral cell surface ( Figures 2C-2E ). In contrast, RhoGEF2 « comets » were completely absent from the cytoplasm in this condition ( Figure 2G , yellow arrowheads; Video S3) and EB1 comets were still present as in controls (Figure 2H ). This suggests that Ga 12/13 /Cta-GTP promotes RhoGEF2 re-localization from microtubule growing ends to the cell membrane upon GPCR activation, as reported in S2 cells [40] . We further tested whether microtubules sequester RhoGEF2 and thereby limit RhoGEF2 membrane recruitment and signaling. Microtubule depolymerization following injection of colcemid caused germ-band extension defects (Figures S2A and S2B) and a medial-apical increase in Myo-II activation together with a decrease in junctional Myo-II ( Figures S2C-S2E ). The medialapical phenotype was similar to RhoGEF2 or Ga 12/13 /Cta overexpression [29] , arguing that microtubules sequester and thereby limit RhoGEF2 signaling medial-apically. Note that, although medial-apical Rho1-GTP levels increased in Ga 12/13 /Cta Q303L -expressing embryos, they were unchanged at junctions (Figures S2E-S2G), consistent with the previous report showing that only medial-apical Myo-II was affected in such conditions [29] . Thus, although active Ga 12/13 /Cta shifts RhoGEF2 distribution from microtubule plus ends to both the medial-apical membrane and cell junctions in the wild-type and in overexpression conditions, RhoGEF2 signaling is consistently restricted to the apical membrane.
Identification of a New RhoGEF Involved in Tissue Extension
The striking apical specificity of RhoGEF2 indicates that other RhoGEF(s) activate junctional Rho1 in the ectoderm. We screened all 26 predicted Drosophila RhoGEFs for defects in germ-band extension by expressing shRNA maternally and zygotically. Knockdown of the maternal contribution was crucial in such experiments, as a strong maternal mRNA loading is observed for a large number of RhoGEFs in the embryo (modENCODE_mRNA-seq; Flybase) [41] . Knockdown of CG10188 (verified at the mRNA and protein levels; Figures S3A and S3B) slowed germ-band extension (Figures 3A and 3B). Notably, intercalation events (also called T1 events), which underlie tissue extension [15, 42] , were significantly decreased in CG10188 shRNA-expressing embryos (Figures 3C and 3D ; Video S4). Severe developmental defects were also observed at later stages, such as the absence of germ-band retraction and the occurrence of cell delamination, resulting in a fully penetrant embryonic lethality (data not shown). We designed a transgene that ubiquitously expresses a modified form of the CG10188 mRNA immune to targeting by the shRNA, although (n = 86/213 embryos) conditions. The egg-hatching percentage was determined as a measurement of embryo viability (STAR Methods). The fully penetrant embryonic lethality observed in CG10188 shRNA embryos is rescued by the expression of the targeted gene refractory to the shRNA (Sqh-CG10188 shRNA R ).
(legend continued on next page) with preserved codon usage (SqhPa-CG10188-shRNA R ; STAR Methods). This transgene rescued lethality in CG10188 shRNA-expressing embryos and proved the specificity of the knockdown ( Figure 3E ). Overall, these results demonstrate a requirement for CG10188 during germ-band extension. CG10188 has not yet been functionally characterized in Drosophila. From sequence and domain similarity, CG10188 is the ortholog of the mammalian RhoGEF subfamily, including p114RhoGEF, AKAP13, GEF-H1, and p190RhoGEF, who each activate RhoA [43, 44] (Figure 3F ). Based on their sequence and function [45] compared with our data hereafter, we conclude that p114RhoGEF is the closest mammalian ortholog of the Drosophila CG10188, and we will now refer to CG10188 as Dp114RhoGEF. Transcriptomic analyses reported a maternal and zygotic expression of Dp114RhoGEF in the embryo, suggesting that the protein could be present and active in the ectoderm [46, 47] .
Dp114RhoGEF Activates Rho1 Signaling at Adherens Junctions in the Ectoderm
To test whether Dp114RhoGEF controls Rho1 activity in the ectoderm, we investigated the distribution of the Rho-GTP biosensor in Dp114RhoGEF shRNA-expressing embryos. In striking contrast to the RhoGEF2 knockdown, medial-apical Rho1-GTP levels were unaffected, whereas junctional Rho1-GTP was strongly decreased (Figures 4A-4C ). The loss of active junctional Rho1 suggested that junctional Myo-II might be affected. Therefore, we analyzed Myo-II::mCherry in control and Dp114RhoGEF shRNA embryos. Similar to Rho1-GTP, junctional Myo-II was strongly reduced and medial-apical Myo-II was preserved (Figures 4D-4F and S3C; Video S5). Importantly, the expression of the Dp114RhoGEF-shRNA R transgene in Dp114RhoGEF shRNA embryos rescued Myo-II junctional levels ( Figures S3D and S3E) . We noticed that Myo-II persisted at cell vertices in the Dp114RhoGEF knockdown ( Figure 4D , bottom right panel). Rho1-GTP is not detected at vertices in this condition ( Figure 4A ), which suggests either a redistribution of remaining active Myo-II in this condition or that Myo-II could be activated through different mechanisms in this compartment. Last, compared to wild-type, E-cadherin levels were globally reduced in Dp114RhoGEF knockdown embryos with a highly discontinuous E-cadherin distribution at junctions ( Figures  S3F-S3H) . Similar E-cadherin defects have been observed upon dominant-negative Rho1 expression and Rho1 inhibition [18, 48, 49] , consistent with the specificity of Dp114RhoGEF for Rho1 signaling.
RhoGEF2 exhibits a dose-dependent effect on medial-apical Rho1 signaling in that overexpression of RhoGEF2 is sufficient to increase medial Rho1-GTPase and Myo-II activation [29, 50] . Therefore, we asked whether increasing Dp114RhoGEF expression levels could, symmetrically, increase Rho1 signaling at junctions. The Dp114RhoGEF levels were increased by driving Dp114RhoGEF wild-type coding sequence under control of the ubiquitous MRLC/Sqh promoter in Myo-II::mCherry embryos. The result was unique and striking: Dp114RhoGEF overexpression led to a global Myo-II junctional increase relative to control with no effect on medial-apical Myo-II (Figures 4G-4I ; Video S6). Myo-II was increased both at transverse (0 -15 ; 63% increase) and vertical junctions (75 -90 ; 200% increase; Figure 4J) , with a resulting modest (24%) increase in planar polarity ( Figure 4K ). Thus, Dp114RhoGEF tunes Rho1 signaling in a dosedependent manner at junctions.
RhoGEF2 and Dp114RhoGEF show complementary spatial restriction of activity on Rho1 signaling. We thus hypothesized that a double knockdown of both RhoGEFs should abolish total Rho1 activity in the ectoderm. Indeed, Rho1-GTP and Myo-II were decreased both apically and at cell junctions in this context ( Figures S4A-S4F ). Together, our data demonstrate that Dp114RhoGEF is a key activator of Rho1 signaling at adherens junctions in the ectoderm. Moreover, RhoGEF2 and Dp114RhoGEF have additive and non-redundant functions in the ectoderm.
Dp114RhoGEF Mediates Gb13F/Gg1-Dependent Junctional Rho1 Signaling Given the critical function of Gb13F/Gg1 in the regulation of medial-apical and junctional Myo-II pools [29] , we examined its link with Dp114RhoGEF at junctions. We first tested whether Rho activity was dependent upon Gb13F/Gg1. We analyzed the Rho1-GTP biosensor distribution in both Gb13F/Gg1 lossof-function (Gg1 germline clone) and gain-of-function (Gb13F/ Gg1 overexpression) conditions. Loss of Gg1 resulted in a reduction of both junctional and medial-apical Rho1-GTP, consistent with the overall reduction in Myo-II previously reported [29] (Figures 5A-5C ). Note that the medial-apical decrease in Rho1 signaling does not imply direct Gb13F/Gg1 activity apically, as this is expected from the known mechanisms controlling heterotrimeric G protein activation. Indeed, the Gbg subunit dimer is necessary to properly localize Ga at the membrane and thereby to prime Ga to respond to GPCR GEF activity [51] [52] [53] . Thus, Gb13F/Gg1 is required for Ga 12/13 /Cta activation (Ga-GTP) downstream of GPCRs, such that loss of Gb13F/Gg1 also causes loss of Ga 12/13 /Cta activity.
We then overexpressed both Gb13F and Gg1 in embryos to test a dose-dependent effect of these subunits on junctional Rho1 signaling. Overexpression of either Gb13F or Gg1 alone did not give any phenotype (data not shown), consistent with studies showing that the individual Gb and Gg subunits can neither be transported to the membrane individually nor bind to or signal via their molecular effectors as monomers [54, 55] . In contrast and remarkably, Gb13F/Gg1 co-expression resulted in a specific enrichment in Rho1 activity at vertical junctions (23% increase) compared to controls ( Figure 5D ). Consequently, Rho1-GTP planar polarity was significantly increased (25% (F) Phylogenetic tree inferred from sequence similarity between the Drosophila CG10188 (Flybase: FBgn0032796) and its human orthologs p114RhoGEF (UniProtKB: Q6ZSZ5-4), GEF-H1 (UniProtKB: Q92974-1), p190RhoGEF (UniProtKB: Q8N1W1-1), and AKAP13 (UniProtKB: Q12802-1). Human sequences were collected from UniProt and clustered by multiple sequence alignment using ClustalOmega (nj tree, no distance correction). CG10188 exhibits a DH-PH tandem characteristic of the Dbl-RhoGEFs and a coil-coiled (CC) motif in its C-terminal region, known to be a dimerization domain in its mammalian counterparts. Scale bars represent 50 mm (A) and 15 mm (C). Error bars, SD for (B) and SEM for (D). See also Figure S3 and Video S4. increase; Figure 5E ). However, medial-apical Rho1 activity was not significantly changed upon Gb13F/Gg1 co-expression, indicating a different sensitivity to Gb13F/Gg1 levels in the apical compared to the junctional compartments ( Figure 5F ). Note that Ga 12/13 /Cta showed the opposite pattern ( Figures S2E-S2G ). Myo-II::mCherry was next examined in Gb13F/Gg1-overexpressing embryos (referred to as Gb13F/Gg1++). Consistent with the previous data, we observed a specific increase of Myo-II at vertical junctions (48% increase; Figures 5G and 5H; Video S7), leading to a strong (2-fold) increase in Myo-II planar polarity ( Figure 5I ). Medial-apical Myo-II levels were unchanged in this condition (data not shown). Because Gb13F/Gg1 overexpression hyperpolarized Myo-II in all the ectodermal cells, the strong parasegmental boundaries cables [56] observed in the wild-type (yellow arrowheads in Figure 5G , left panel) were now indistinguishable from the other vertical interfaces (orange arrowheads in Figure 5G , right panel). However, despite a clear effect on junctional Myo-II, the rate of germ-band extension was not affected upon Gb13F/Gg1 overexpression (data not shown).
Altogether, we uncovered a new role for Gb13F/Gg1 dimer, which is involved quantitatively in the planar polarization of Rho1 signaling at junctions. Therefore, both Gb13F/Gg1 and Dp114RhoGEF regulate junctional Myo-II by quantitatively tuning Rho1 activation at junctions.
These results suggested that Dp114RhoGEF might be genetically epistatic to Gb13F/Gg1. Thus, we investigated Gb13F/Gg1 overexpression in conjunction with Dp114RhoGEF shRNA to explore this relationship. To avoid any differential titration of Gal4 effects, the number of UAS regulatory sequences was equivalent in both the Gb13F/Gg1++ and the Gb13F/Gg1++, Dp114RhoGEF shRNA embryos (STAR Methods). The polarized increase in Myo-II at vertical junctions in Gb13F/Gg1++ embryos was no longer observed in Gb13F/Gg1++, Dp114RhoGEF shRNA embryos ( Figure 6A ), which were indistinguishable from Dp114RhoGEF shRNA embryos alone (Figures 6B and 6C ; compare with Figures 4D, S3A, and S3B) . Overall, these data show that Dp114RhoGEF is crucial to mediate Gb13F/Gg1-dependent Rho1 signaling at junctions.
Gb13F/Gg1 Regulates Dp114RhoGEF Junctional Enrichment in the Ectoderm
The new genetic interaction between Gb13F/Gg1 and Dp114RhoGEF led us to ask whether Gb13F/Gg1 subunits could activate and/or localize Dp114RhoGEF at junctions. First, we assessed their respective subcellular distribution in vivo. Transgenic lines that express Dp114RhoGEF tagged with either N-terminal or C-terminal GFP were generated (STAR Methods). Embryos expressing GFP-tagged Dp114RhoGEF and Myo-II::mCherry were imaged. We found that Dp114RhoGEF::GFP localization was restricted to adherens junctions, where it forms puncta in both N-and C-terminal GFP fusions (Figures 7A and  S5A) . Remarkably, although expressed ubiquitously in the embryo, Dp114RhoGEF::GFP was not detected at junctions in the mesoderm ( Figure 7B ). It has been reported that Rho1 signaling in mesodermal cells is induced medial-apically and absent from junctions [24] . Therefore, a mesoderm-specific regulation is likely to block junctional Rho1 signaling in this tissue via Dp114RhoGEF mRNA or protein degradation, because we failed to detect any increase in cytoplasmic Dp114RhoGEF::GFP signal in these cells ( Figure 7B ).
Planar-polarized Rho1 activity at ectodermal junctions could be explained by a planar-polarized distribution of its direct activator(s) in the ectoderm. To test this hypothesis, we next compared junctional Dp114RhoGEF distribution with the distribution of the non-polarized membrane protein GAP43 in the ectoderm of the same embryos. No difference was observed between Dp114RhoGEF and GAP43 amplitude of polarity (Figures S5B and S5C) . Thus, Dp114RhoGEF localization alone cannot account for the polarized Rho signaling at junctions.
Alternatively, Dp114RhoGEF activity could be polarized at junctions. Considering the newly uncovered genetic interaction between Dp114RhoGEF and Gb13F/Gg1 in the control of junctional Rho1 signaling, we hypothesized that the heterotrimeric G proteins could be upstream activators of Dp114RhoGEF. Thus, the localization of Gb13F/Gg1 could instruct planar polarization of Dp114RhoGEF activity. We generated antibodies against two different peptides of Gb13F (STAR Methods) and confirmed their specificity by western blot and immunochemistry analyses (Figures S6A-S6C ). Both antibodies revealed an apical and junctional enrichment of Gb13F in the ectoderm ( Figure S6C ). Furthermore, Gb13F co-localizes with both Dp114RhoGEF and b-catenin at junctions ( Figures 7C and S6D , respectively), where it is not planar polarized ( Figure S6E ).
Finally, we asked whether Gb13F/Gg1 controls Dp114RhoGEF enrichment at junctions. We looked at Dp114RhoGEF::GFP signal in both gain (Gb13F/Gg1++) and loss of Gb13F/Gg1 
, and Gb13F/Gg1-overexpressing embryos (Gb13F/Gg1++).
(legend continued on next page) (Gb13F/Gg1À). Dp114RhoGEF was decreased at junctions upon Gg1 depletion (Figures 6D and 6E) . Conversely, Gb13F/Gg1 overexpression led to an increase in Dp114RhoGEF levels at junctions, though strikingly without any gain in planar polarity ( Figures  7F, 7G, and S6F ), which contrasts with the gain in Rho1-GTP and Myo-II planar polarity in this condition. Taken together, our data show that Gb13F/Gg1 subunits are present at adherens junctions, where they increase recruitment of Dp114RhoGEF, allowing Rho1 to signal efficiently in this compartment.
DISCUSSION
Critical aspects of cell mechanics are governed by spatialtemporal control over Rho1 activity during Drosophila embryo morphogenesis. This work sheds new light on the mechanisms underlying polarized Rho1 activation during intercalation in the ectoderm. We found that Rho1 activity is driven by two complementary RhoGEFs under spatial control of distinct heterotrimeric G protein subunits ( Figure S7 ). Notably, we uncovered a regulatory module specific for junctional Rho1 activation.
We identified Dp114RhoGEF as a novel activator of junctional Rho1 in the extending ectoderm. Hence, two RhoGEFs, Dp114RhoGEF and RhoGEF2, coordinate independently the modular Rho signaling during tissue extension of the ectoderm. This has important implications, as it allows us to refine the nature of the interconnection between the two pools of Myo-II in this tissue. We showed previously that medial pulses of Myo-II flow toward and merge with the Myo-II pool at vertical junctions [17] . However, to what extent these ''fusion'' events contribute to junctional Myo-II was unclear. In the present study, we genetically uncoupled the regulation of both pools of Myo-II and showed that the loss of one pool does not compromise activation of Myo-II in the other. Indeed, junctional Myo-II levels and planar polarity are not affected in RhoGEF2 shRNA embryos or in RhoGEF2 germline clone where medial Myo-II is lost. This rules out the possibility of medial pulses being the main source of junctional Myo-II accumulation. Instead, we conclude that actomyosin flow toward junctions contributes to junction shrinkage because it serves a distinct and direct mechanical function in junction remodeling rather than working by proxy by fueling junctional Myo-II.
The division of labor in the molecular mechanisms of Rho1 activation in distinct cellular compartments lends itself to differential quantitative regulation. The activation kinetics of these different GEFs and nucleotide exchange catalytic efficiencies are likely to differentially impact Rho1 activity and therefore Myo-II activation at the junctional and medial-apical compartments. For example, RhoGEF2 mammalian orthologs, LARG and PDZ-RhoGEF, show a catalytic activity that is two orders of magnitude higher as compared with the Dp114RhoGEF orthologs subfamily [57] . This may help to establish specific contractile regimes of actomyosin in given subcellular compartments. It is therefore important to tightly control RhoGEFs localization and activity to ensure a proper quantitative activation of the downstream GTPase.
RhoGEF2 is a major regulator of medial-apical Rho1 activity during Drosophila gastrulation [34, 37, 58] . Originally characterized in the invaginating mesoderm, we found that RhoGEF2 also activates Rho1 medial-apical activity in the elongating ectoderm. There, RhoGEF2 localizes both medial-apically and at junctions where it is also planar polarized. Although RhoGEF2 and active Rho1 are both planar polarized at junctions, in RhoGEF2 mutants, junctional Rho1-GTP is not affected and ectopic recruitment of RhoGEF2 following expression of Ga 12/13 Q303L does not cause ectopic junctional Rho1-GTP accumulation. Thus, RhoGEF2 localization at the membrane is not strictly indicative of its activation status. Interestingly, Ga 12/13 / Cta is necessary for RhoGEF2 to translocate from microtubules plus ends to the plasma membrane where it signals. To date, experimental evidence favor a model whereby the binding of active Ga 12/13 /Cta to the RhoGEF in the vicinity of the cell membrane triggers its conformational change and stabilizes it in an open conformation able to bind to lipids via its PH domain and signal at the plasma membrane [28] . There is no evidence that Ga 12/13 /Cta-GTP actively destabilizes RhoGEF2-EB1 interaction, but this is a formal possibility to be tested. Importantly, Ga 12/13 /Cta alone does not account for the restricted activation of Rho1 medial-apically.
We hypothesize that additional factors must regulate the spatial distribution of RhoGEF2 activity. In principle, RhoGEF2 signaling activity could either be specifically induced medialapically independent of RhoGEF2 recruitment or RhoGEF2 could be inhibited at junctions and laterally. Sequestration of inactive See also Figure S7 and Video S7.
RhoGEFs at cell junctions has been reported previously in mammalian cell cultures [59, 60] , suggesting that such mechanism could be evolutionary conserved. Phosphorylation can control the activity of the RH-RhoGEFs subfamily [61, 62] . Therefore, phosphorylation could promote activation or inhibition of RhoGEF2 activity in specific subcellular compartments in the ectoderm. RhoGEF2 is reported to be phosphorylated in the gastrulating embryo [63] .
Complementary to RhoGEF2, Dp114RhoGEF activates junctional Rho1 in the ectoderm. Dp114RhoGEF strictly localizes at junctions (Figure 7A ), providing a direct explanation for its junctional-specific effect. We showed that Gb13F/Gg1 is also enriched at adherens junctions, where it controls Dp114RhoGEF junctional recruitment together with additional upstream regulators ( Figures 7D-7G) . Therefore, we suggest that Gb13F/Gg1-dependent tuning of junctional Rho1 activation could be achieved through its ability to concentrate the GEF at junctions. Gb/Gg-dependent regulation of RhoGEFs has been described in mammals [64, 65] . One study proposes that mammalian p114RhoGEF may bind and be activated by Gb1/Gg2 [64] . Interestingly, recent work demonstrates that Ga 12 can also recruit p114RhoGEF at cell junctions under mechanical stress in mammalian cell cultures where it promotes RhoA signaling [66] . However, the region of mammalian p114RhoGEF that binds to Ga 12 is absent in invertebrate RhoGEFs [67] . How Gb13F/Gg1 controls Dp114RhoGEF at junctions in the Drosophila embryo remains an open question. A recent study reports that Dp114RhoGEF localizes at adherens junctions in the Drosophila ectoderm through multiple mechanisms, including interactions with Baz/Par3 and the Crumbs complex [68] . Therefore, investigating a possible connection between Gb13F/Gg1 signaling and Baz/Crumbs should help decipher the mechanisms of Dp114RhoGEF localization.
Importantly, neither Gb13F/Gg1 nor Dp114RhoGEF are themselves planar polarized at junctions. Hence, their distribution alone cannot explain polarized Rho1 activity at junctions. Strikingly, we found that an increase in Gb13F/Gg1 dimers hyperpolarizes Rho1 activity and Myo-II at vertical junctions ( Figure 5H ). Gb13F/Gg1 overexpression also leads to an overall increase in Dp114RhoGEF levels at junctions, although Dp114RhoGEF is not planar polarized in this condition. This indicates that recruitment at the plasma membrane and activation of Dp114RhoGEF are independently regulated, similar to RhoGEF2. In contrast, Dp114RhoGEF overexpression increases Myo-II at both transverse and vertical junctions, although a slightly stronger accumulation is observed at vertical junctions ( Figures 4J and  4K) . Therefore, although Dp114RhoGEF junctional levels are increased in both experiments, only Gb13F/Gg1 overexpression leads to an increased planar polarization of Rho1-GTP and Myo-II at vertical junctions. This points to a key role for Gb13F/Gg1 subunits in the planar-polarization process associated with but independent from the sole recruitment of Dp114RhoGEF at junctions. In principle, Gb13F/Gg1 could bias junctional Rho1 signaling either by promoting its activation at vertical junctions or by inhibiting it at transverse junctions (e.g., RhoGAP polarized activation). Gb13F/Gg1 could also control active Rho1 distribution independent of its activation. For instance, a scaffolding protein binding to Rho1-GTP at junctions could be polarized by Gb13F/Gg1 to bias Rho1-GTP distribution downstream of its activation. Anillin, a Rho1-GTP anchor known to stabilize Rho1 signaling at cell junctions [69] , is a potential candidate in the ectoderm. Last, Toll receptors control Myo-II planar polarity in the ectoderm [36] . Whether Gb13F/Gg1 and Tolls are part of the same signaling pathway is an important point yet to address in the future.
Finally, our study sheds light on new regulatory differences underlying tissue invagination and tissue extension. Here, we found that Dp114RhoGEF localizes at junctions in the ectoderm, where it activates Rho1 and Myo-II. In contrast, maternally and zygotically supplied Dp114RhoGEF::GFP is not detected at junctions in the mesoderm. We see little if any cytoplasmic signal in this condition, suggesting that Dp114RhoGEF::GFP could be degraded in these cells. Thus, repression of Dp114RhoGEF protein in the mesoderm could be an important mechanism for cell apical constriction and proper tissue invagination. Of interest, Rho1 signaling is absent at junctions in the mesoderm [20] . Therefore, it is tempting to suggest that the absence of Dp114RhoGEF at junction in the mesoderm accounts for cells' inability to activate Rho1 in this compartment. Importantly, the GPCR Smog and Gb13F/Gg1 subunits, found to control junctional Rho1 in the ectoderm, are common to both tissues [29] . Dp114RhoGEF differential expression and/or subcellular localization could be a key element to bias signaling toward junctional compartment in the ectoderm.
Cell contractility necessitates activation of the Rho1-RockMyoII core pathway. During epithelial morphogenesis, tissueand cell-specific regulation of Rho1 signaling requires the diversification of Rho1 regulators, in particular RhoGEFs, as shown in this study, and RhoGAPs. Some of them are tissue specific with given subcellular localizations and activation mechanisms. The identification of signaling modules, namely Ga 12/13 -RhoGEF2 and Gb13F/Gg1-Dp114RhoGEF, provides a simple mechanistic framework for explaining how tissue-specific modulators control Rho1 activity in a given subcellular compartment in a given cell type. Therefore, we suggest that the variation of (1) ligands, GPCRs, and associated heterotrimeric G proteins and (2) types of RhoGEFs and RhoGAPs as well as their combination, activation, and localization by respective co-factors underlies the context-specific control of Rho1 signaling during tissue morphogenesis. How developmental patterning signals ultimately control Rho regulators is an exciting area for future investigations.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Halocarbon oil 200 to cover embryos before live imaging. The embryos were prepared as described in [46] . Please refer to the Key Resources Table for the details of the fly lines being used.
METHOD DETAILS
Transgenic lines
All fly constructs are listed in the Key Resources Table. 67-Gal4 (mat-4-GAL-VP16), nos-Gal4 and 15-Gal4 are ubiquitous, maternally supplied, Gal4 drivers. Germline clones for Gg1 N159 and RhoGEF2 l(2)04291 were made using the FLP-DFS system [80] . SqhPa-Dp114RhoGEF expression vectors were generated using a SqhPa-sqh::mCherry modified vector (kind gift from A. Martin), a pCasper vector containing a sqh (MyoII RLC, CG3595) minimal promoter. A PhiC31 attB sequence was inserted downstream of the white gene of the SqhP vector into AfeI restriction site to perform PhiC31 site specific transgenesis. To build SqhPa-Dp114RhoGEF plasmids, ORF of sqh::mCherry was replaced by the one of Dp114RhoGEF (CG10188) using 2 ESTs as matrices (RE42026 and RE33026) to build a WT sequence (Genebank: NP_609977). Dp114RhoGEF was then tagged either N-or C-terminally by mEGFP with a SGGGGS flexible aa linker in between. SqhPa-Dp114RhoGEF (CG10188) -shRNA R Resistant and SqhPa-eGFP:: Dp114RhoGEF (CG10188) -shRNA R Resistant were built by introducing silent point mutations to the codons of the 21bp targeted by the shRNA TRIP 41579 (CACGAGACAGACAATGGATTA to CAtGAaACtGAtAAcGGtTTA). All recombinant expression vectors were verified by sequence (Genewiz) and were sent to BestGene Incorporate for PhiC31 site specific mediated insertion into attP2 (3L, 68A4). FASTA sequences of these vectors are available on request.
Fly genetics F1 progeny (embryos) were analyzed for following crosses: Figure 1A ; Image acquisition Embryos were prepared as described before [46] . Timelapse imaging was done from stage 6 during 15 to 30 min depending on the experiment, on a Nikon Roper spinning disc Eclipse Ti inverted microscope using a 100X_1.4 N.A. oil-immersion objective or a 40X _1.25 N.A. water-immersion (for cell-intercalation measurement) at 22 C. The system acquires images using the Meta-Morph software. For medial and junctional intensity measurements, 10 to 18 Z sections (depending on the experimental conditions), 0.5mm each, were acquired every 15 s. Laser power was measured and kept constant across all experiments.
Image analysis All image processing was done in imageJ/Fiji free software. For all quantifications for medial and junctional Rho1-GTP and Myo-II, maximum-intensity z-projection of slices was used, followed by a first background subtraction using the rolling ball tool (radius 50 pixels$4mm) and a second subtraction where mean cytoplasmic intensity value measured on the projected stack was subtracted to the same image. Cell outlines were extracted from spinning disk confocal images of Ecad::GFP or Rho1-GTP using the Tissue Analyzer software [79] from B.Aigouy (IBDM, France). The Ecad-GFP resulting outlines were then dilated by 2 pixels on either side of the junction (5-pixel-wide lines) and used as a junctional mask on the MyoII::mCherry channel. Medial-apical area was obtained by shrinking individual cell mask by 4 pixels to exclude any contribution of junctional signal (ImageJ/Fiji macro from G. Kale [8] , COS Heidelberg). Medial and junctional Myo-II and Rho1-GTP values were mean intensities calculated in these two non-overlapping cell areas.
For planar polarity analysis, junctional masks described previously were used to extract for each junction the mean pixel intensity and orientation. Intensities were averaged for all junctions in each angular range. Amplitude of polarity was then calculated as a ratio between signal intensity measured at vertical junctions (75) (76) (77) (78) (79) (80) (81) (82) (83) (84) (85) (86) (87) (88) (89) (90) angular range) over intensity measured at transverse junctions (0-15 angular range).
To measure the number of T1 transitions, Tissue Analyzer software. Segmentation was automatically performed on Utr::GFP channel by the plugin and corrected by the experimenter. Tracked cells present in the field of view during a period of 10min were then analyzed for T1 events. T1 events were automatically detected by the plugin and checked manually to prevent false detections.
QUANTIFICATION AND STATISTICAL ANALYSIS Statistics
Errors bars are SEM unless otherwise indicated. Statistical significance was determined and P values calculated with a non-parametric Mann-Whitney U test or a Kolmogorov-Smirnov two-sample test in OriginPro9. The experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment.
DATA AND CODE AVAILABILITY
This study did not generate new datasets and code.
